BioCentury
ARTICLE | Politics & Policy

Senate price gouging panel doesn’t recommend price controls

December 22, 2016 12:12 AM UTC

In a report on allegedly unjustified price increases of off-patent drugs, the U.S. Senate Committee on Aging recommended legislative remedies that would support generic competition and prevent market manipulation but did not recommend government step in directly to control drug prices.

Sens. Susan Collins (R-Maine) and Claire McCaskill (D-Mo.) launched the investigation in November 2015. Collins is the committee chair, and McCaskill its ranking member...